Foxiga Korea Local Phase 4 Study - BEYOND

Exclusion Criteria

• 1. Type 1 diabetes or history of diabetic ketoacidosis
• 2. Pregnant or breast-feeding patients
• 3. eGFR < 60 mL/min/1.73 m2 (MDRD) on visit 1.
• 4. Indication of active liver disease (AST/ALT/total bilirubin > 3 X upper limits of normal) on visit 1.
• 5. Acute coronary syndrome, stroke or TIA within 3 months prior to randomization
• 6. Bariatric surgery within 2 years; treatment of anti-obesity drugs 3 months prior to randomization; any treatment leading to unstable body weight. (Unstable body weight is considered reliable in the judgment of the Investigator.)
• 7. History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis at any time
• 8. History of any other malignancy within 5 years (with the exception of successfully treated non-melanoma skin cancers)
• 9. History of alcohol or drug abuse judged by physician within 3 months prior to randomization
• 10. Concomitant participation in any other clinical study.